STEM CELLS Translational Medicine

STEM CELLS Translational Medicine

STEM CELLS Translational Medicine is the official scientific journal of the Cord Blood Association.  The monthly online peer-reviewed journal, published by AlphaMed Press, presents articles on umbilical cord blood and tissue banking, cord blood and cord tissue therapies, engineering and manufacturing of cord blood immune cells, and the use of cord blood and cord tissue in regenerative medicine.

 

Publication fees are waived for CBA members.

“The Cord Blood Association is excited and honored to partner with STEM CELLS Translational Medicine to showcase the newest and highest quality translational and clinical applications of cord blood and cord tissue based therapies,” said Joanne Kurtzberg, MD, CBA president. “The mission and goals of both parties are aligned to maximize sharing of advances in these novel cell and tissue based therapies.”

“We are delighted to initiate this partnership with the Cord Blood Association,” said Anthony Atala, MD, Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.  “With this new collaboration, SCTM further expands the scope of new research reports for our readers – with the potential to accelerate progress in regenerative medicine.”